Nextage Therapeutics (XTAE:NXTG) Days Sales Outstanding : 32.89 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Days Sales Outstanding?

Nextage Therapeutics's average Accounts Receivable for the six months ended in Dec. 2023 was ₪0.13 Mil. Nextage Therapeutics's Revenue for the six months ended in Dec. 2023 was ₪0.71 Mil. Hence, Nextage Therapeutics's Days Sales Outstanding for the six months ended in Dec. 2023 was 32.89.

The historical rank and industry rank for Nextage Therapeutics's Days Sales Outstanding or its related term are showing as below:

XTAE:NXTG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.04 Med: 40.13 Max: 104.29
Current: 37.5

During the past 8 years, Nextage Therapeutics's highest Days Sales Outstanding was 104.29. The lowest was 18.04. And the median was 40.13.

XTAE:NXTG's Days Sales Outstanding is ranked better than
82.68% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.3 vs XTAE:NXTG: 37.50

Nextage Therapeutics's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (32.89).

Nextage Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Nextage Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Days Sales Outstanding Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

18.04

24.84

104.29

55.42

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial									-	-	-	9.52	32.89

Competitive Comparison of Nextage Therapeutics's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's Days Sales Outstanding falls into.

Nextage Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nextage Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.013	+	0.253)	/	2 )	/	0.876	*	365
=	0.133					/	0.876	*	365
=	55.42

Nextage Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.004	+	0.253)	/	2 )	/	0.713	*	365 / 2
=	0.1285					/	0.713	*	365 / 2
=	32.89

Nextage Therapeutics (XTAE:NXTG) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Nextage Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021